Accula SARS-CoV-2 Test

• Easy-to-use, uniquely rapid diagnostic solution amalgamates the efficiency of RT-PCR with the simplicity, ease, and procedural knowledge of conventional rapid immunoassays.
• The Accula System from Thermo Fisher Scientific has received Emergency Use Authorization from the FDA for SARS-CoV-2 detection in Clinical laboratory improvement amendments- waived environments.
• The compact Accula Dock provides assists with reliable and qualitative results in no time.

How regular testing works?

The 30 minutes game changer

Testing made effortless

What makes Accula Dock stand out?

• Instant screening
• Faster than regular RT-PCR
• Approved by FDA
• Easy operation
• No dedicated storage or transportation equipment required

“Getting tested for COVID-19 is the key to get back to normal”